THEMISMEDNSEThemis Medicare Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 8 Apr · 15:35 IST

Dr. Dinesh S. Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

THEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.2%1-day move
₹81.11
prior close
₹81.82
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.4+1.7+1.6-0.1+3.2+1.3+4.8+5.0+10.6+14.0+21.8+28.3+31.8+44.1
Up moveDown movePending
AI summary

Dr. Dinesh S. Patel, Promoter of Themis Medicare Limited, has submitted a disclosure under SEBI Regulation 31(4). The filing confirms that Dr. Patel and all persons acting in concert (PAC) have NOT created any encumbrance (pledge) over their shares during the financial year ended 31st March 2026. The disclosure lists 13 entities in the promoter/promoter group including family members and related entities like Vividhmargi Investments Pvt Ltd. The filing also notes that a prior pledge by Vividhmargi Investments during 2023-24 had already been disclosed to exchanges.

Likely market impact

Positive for shareholders as it confirms promoters have not pledged their shares, reducing risk of forced selling. The absence of new encumbrances indicates promoter confidence in the company.